%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Delphine L. Chen, Howard J. Huang, Derek E. Byers, Adrian Shifren, Bryan Belikoff, Jacquelyn T. Engle, Elizabeth Arentson, Debra Kemp, Sharon Phillips, David E. Scherrer, Hideji Fujiwara, Katherine J. Spayd, Frank J. Brooks, Richard A. Pierce, Mario Castro, Warren Isakow
The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 14 0 R/Contents 15 0 R/TrimBox[0 0 612 792]>>
endobj
14 0 obj
[16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R]
endobj
16 0 obj
<>/Border[0 0 0]/A 29 0 R>>
endobj
29 0 obj
<>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0191783.ref001)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0191783.ref002)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0191783.ref011)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0191783.ref012)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0191783.ref013)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0191783.ref016)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0191783.ref017)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0191783.ref018)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0191783.ref019)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0191783.ref020)>>
endobj
27 0 obj
<>/Border[0 0 0]/A 30 0 R>>
endobj
30 0 obj
<>
endobj
28 0 obj
<>/Border[0 0 0]/A 31 0 R>>
endobj
31 0 obj
<>
endobj
15 0 obj
[32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R]
endobj
32 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 411.0574 m
199.9998 411.0574 l
199.9998 411.5574 l
575.9997 411.5574 l
f*
0.83 0.64 0.02 0 k
272.9197 423.4961 m
334.0346 423.4961 l
h
f*
354.5575 315.9496 m
359.3197 315.9496 l
h
f*
420.2646 289.9276 m
425.0268 289.9276 l
h
f*
430.2425 289.9276 m
439.7102 289.9276 l
h
f*
445.6063 263.9055 m
455.1307 263.9055 l
h
f*
454.1102 237.9402 m
463.6346 237.9402 l
h
f*
468.7937 237.9402 m
478.3181 237.9402 l
h
f*
303.4205 185.8961 m
312.9449 185.8961 l
h
f*
317.3669 185.8961 m
326.8913 185.8961 l
h
f*
558.4252 146.948 m
567.9496 146.948 l
h
f*
475.937 120.926 m
485.4614 120.926 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(determined)Tj
5.162 0 Td
(by)Tj
1.2651 0 Td
(enzyme-linked)Tj
6.5943 0 Td
(immunosorbent)Tj
7.0418 0 Td
(assay,)Tj
3.0793 0 Td
(to)Tj
1.0503 0 Td
(verify)Tj
2.584 0 Td
(treatment)Tj
4.4041 0 Td
(compliance.)Tj
5.4963 0 Td
(One-)Tj
-36.6772 -1.474 Td
(or)Tj
1.098 0 Td
(two-way)Tj
3.8491 0 Td
(analysis)Tj
3.7895 0 Td
(of)Tj
1.0443 0 Td
(variance)Tj
3.9506 0 Td
(assessed)Tj
4.4042 0 Td
(for)Tj
1.3725 0 Td
(differences)Tj
5.0606 0 Td
(among)Tj
3.2404 0 Td
(cohorts)Tj
3.4672 0 Td
(in)Tj
0.9847 0 Td
(the)Tj
1.5934 0 Td
(outcome)Tj
-33.8545 -1.474 Td
(measures)Tj
4.5652 0 Td
(\(expressed)Tj
5.1143 0 Td
(as)Tj
1.2651 0 Td
(mean)Tj
/F5 1 Tf
2.6974 0 Td
[( )]TJ
/F0 1 Tf
0.7579 0 Td
(standard)Tj
4.064 0 Td
(deviation\).)Tj
ET
Q
q
1 j
1 J
0 w
11.4998 0 0 11.4998 200.0125 653.6692 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Results)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 636.6614 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(Ten)Tj
1.9275 0 Td
(females)Tj
3.688 0 Td
(and)Tj
1.8619 0 Td
(eight)Tj
2.3572 0 Td
(males)Tj
2.8645 0 Td
(\(29)Tj
/F5 1 Tf
[( )]TJ
/F0 1 Tf
(6)Tj
2.7332 0 Td
(years)Tj
2.6377 0 Td
(of)Tj
1.0443 0 Td
(age\))Tj
2.1961 0 Td
(completed)Tj
4.7861 0 Td
(all)Tj
1.1995 0 Td
(study)Tj
2.584 0 Td
(procedures)Tj
5.168 0 Td
(except)Tj
3.139 0 Td
(for)Tj
-38.187 -1.474 Td
(one)Tj
1.8619 0 Td
(volunteer)Tj
4.2847 0 Td
(who)Tj
2.035 0 Td
(did)Tj
1.5337 0 Td
(not)Tj
1.5934 0 Td
(complete)Tj
4.231 0 Td
(the)Tj
1.5994 0 Td
(post-endotoxin)Tj
6.7016 0 Td
(BAL.)Tj
/F6 1 Tf
2.3692 0 Td
(K)Tj
ET
Q
q
1 j
1 J
0 w
7.1248 0 0 6.3325 455.3574 621.0708 cm
BT
/F0 1 Tf
1 TL
-0.0056 Tc
0 0 Td
(i)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 458.9291 622.6582 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(and)Tj
1.8678 0 Td
(SUV)Tj
ET
Q
q
1 j
1 J
0 w
7.1248 0 0 6.3325 496.0629 621.0708 cm
BT
/F0 1 Tf
1 TL
-0.0056 Tc
0 0 Td
(mean)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 515.7354 622.6582 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(increased)Tj
4.4996 0 Td
(in)Tj
-37.7334 -1.474 Td
(all)Tj
1.1995 0 Td
(cohorts)Tj
3.4612 0 Td
(after)Tj
2.2021 0 Td
(endotoxin)Tj
4.5056 0 Td
(instillation)Tj
4.5413 0 Td
(\()Tj
/F6 1 Tf
(K)Tj
ET
Q
q
1 j
1 J
0 w
7.1248 0 0 6.3325 360.5669 607.0677 cm
BT
/F0 1 Tf
1 TL
-0.0056 Tc
0 0 Td
(i)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 364.1952 608.6551 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(increased)Tj
4.4996 0 Td
(by)Tj
1.2651 0 Td
(0.0021)Tj
/F5 1 Tf
[( )]TJ
/F0 1 Tf
(0.0019)Tj
6.5823 0 Td
(,)Tj
0.4953 0 Td
(0.0023)Tj
/F5 1 Tf
[( )]TJ
/F0 1 Tf
(0.0017)Tj
6.5824 0 Td
(,)Tj
0.4953 0 Td
(and)Tj
-37.2023 -1.474 Td
(0.0024)Tj
/F5 1 Tf
[( )]TJ
/F0 1 Tf
(0.0020)Tj
6.7972 0 Td
(and)Tj
1.8679 0 Td
(SUV)Tj
ET
Q
q
1 j
1 J
0 w
7.1248 0 0 6.3325 301.7196 593.0645 cm
BT
/F0 1 Tf
1 TL
-0.0056 Tc
0 0 Td
(mean)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 321.3921 594.6519 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(by)Tj
1.2651 0 Td
(0.47)Tj
/F5 1 Tf
[( )]TJ
/F0 1 Tf
(0.14,)Tj
4.8815 0 Td
(0.55)Tj
/F5 1 Tf
[( )]TJ
/F0 1 Tf
(0.15,)Tj
4.8875 0 Td
(and)Tj
1.862 0 Td
(0.54)Tj
/F5 1 Tf
[( )]TJ
/F0 1 Tf
(0.38)Tj
4.607 0 Td
(in)Tj
0.9846 0 Td
(placebo,)Tj
3.9506 0 Td
(pioglita-)Tj
-35.215 -1.474 Td
(zone,)Tj
2.6377 0 Td
(and)Tj
1.8679 0 Td
(zileuton)Tj
3.6164 0 Td
(cohorts,)Tj
3.7477 0 Td
(respectively,)Tj
5.7109 0 Td
(p)Tj
/F5 1 Tf
[( )]TJ
/F0 1 Tf
(0.001\))Tj
4.1535 0 Td
(with)Tj
1.9753 0 Td
(no)Tj
1.3188 0 Td
(differences)Tj
5.0547 0 Td
(among)Tj
3.2464 0 Td
(treatment)Tj
-33.3293 -1.474 Td
(cohorts)Tj
3.4672 0 Td
(\(p)Tj
1.0981 0 Td
(=)Tj
0.7996 0 Td
(0.933\).)Tj
3.3001 0 Td
(Adiponectin)Tj
5.3768 0 Td
(levels)Tj
2.7391 0 Td
(increased)Tj
4.5056 0 Td
(as)Tj
1.2652 0 Td
(expected)Tj
4.231 0 Td
(with)Tj
1.9753 0 Td
(pioglitazone)Tj
5.4843 0 Td
(treatment)Tj
-34.2423 -1.468 Td
(but)Tj
1.5934 0 Td
(not)Tj
1.5933 0 Td
(urinary)Tj
3.2405 0 Td
(LTE)Tj
ET
Q
q
1 j
1 J
0 w
7.1248 0 0 6.3325 278.3622 551.1118 cm
BT
/F0 1 Tf
1 TL
-0.0056 Tc
0 0 Td
(4)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 284.3716 552.6992 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(levels)Tj
2.7391 0 Td
(as)Tj
1.2651 0 Td
(expected)Tj
4.2371 0 Td
(with)Tj
1.9753 0 Td
(zileuton)Tj
3.6164 0 Td
(treatment.)Tj
4.6846 0 Td
(BAL)Tj
2.0946 0 Td
(cell)Tj
1.6948 0 Td
(counts)Tj
3.139 0 Td
(\(p)Tj
1.0981 0 Td
(=)Tj
0.7996 0 Td
(0.442\))Tj
-36.2235 -1.474 Td
(and)Tj
1.8619 0 Td
(neutrophil)Tj
4.5533 0 Td
(percentage)Tj
5.1619 0 Td
(\(p)Tj
1.0981 0 Td
(=)Tj
0.7996 0 Td
(0.773\))Tj
3.0256 0 Td
(were)Tj
2.3632 0 Td
(similar)Tj
3.0674 0 Td
(among)Tj
3.2464 0 Td
(the)Tj
1.5934 0 Td
(treatment)Tj
4.4101 0 Td
(cohorts.)Tj
ET
Q
q
1 j
1 J
0 w
11.4998 0 0 11.4998 200.0125 512.6173 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusions)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 495.6094 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(Endotoxin-induce)Tj
7.6326 0 Td
(d)Tj
0.7638 0 Td
(lung)Tj
2.0828 0 Td
(inflammation)Tj
5.8244 0 Td
(in)Tj
0.9846 0 Td
(humans)Tj
3.7418 0 Td
(is)Tj
0.9309 0 Td
(not)Tj
1.5934 0 Td
(responsive)Tj
5.0009 0 Td
(to)Tj
1.0443 0 Td
(pioglitazone)Tj
5.4783 0 Td
(or)Tj
1.0981 0 Td
(zileu-)Tj
-36.1759 -1.474 Td
(ton,)Tj
1.8738 0 Td
(highlighting)Tj
5.1978 0 Td
(the)Tj
1.5934 0 Td
(challenge)Tj
4.4399 0 Td
(in)Tj
0.9787 0 Td
(translating)Tj
4.7741 0 Td
(anti-inflamm)Tj
5.3888 0 Td
(atory)Tj
2.4229 0 Td
(drug)Tj
2.1901 0 Td
(efficacy)Tj
3.5806 0 Td
(results)Tj
3.133 0 Td
(from)Tj
-35.5731 -1.474 Td
(murine)Tj
3.2404 0 Td
(models)Tj
3.4075 0 Td
(to)Tj
1.0444 0 Td
(humans.)Tj
ET
Q
q
1 j
1 J
0 w
11.4998 0 0 11.4998 200.0125 441.5811 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Trial)Tj
2.317 0 Td
(registration)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 424.5732 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(ClinicalTrials.gov)Tj
0.83 0.64 0.02 0 k
7.6744 0 Td
(NCT01174056)Tj
0 g
(.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 360 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 342.9921 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Lung)Tj
2.296 0 Td
(diseases)Tj
3.3789 0 Td
(contribute)Tj
4.3936 0 Td
(significantly)Tj
5.091 0 Td
(to)Tj
1.0262 0 Td
(overall)Tj
2.9026 0 Td
(morbidity)Tj
4.2406 0 Td
(and)Tj
1.7292 0 Td
(mortality.)Tj
4.1385 0 Td
(Chronic)Tj
3.532 0 Td
(lower)Tj
2.4491 0 Td
(respi-)Tj
-35.1777 -1.2982 Td
(ratory)Tj
2.6532 0 Td
(diseases,)Tj
3.6056 0 Td
(such)Tj
2.0579 0 Td
(as)Tj
1.0148 0 Td
(chronic)Tj
3.2939 0 Td
(obstructive)Tj
4.6544 0 Td
(pulmonary)Tj
4.6488 0 Td
(disease)Tj
3.0161 0 Td
(\(COPD\))Tj
3.6056 0 Td
(and)Tj
1.7291 0 Td
(asthma,)Tj
3.3222 0 Td
(are)Tj
1.4514 0 Td
(the)Tj
-35.053 -1.2983 Td
(third)Tj
2.211 0 Td
(leading)Tj
3.1351 0 Td
(cause)Tj
2.3867 0 Td
(of)Tj
1.0148 0 Td
(death)Tj
2.4321 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(US)Tj
1.4287 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.6044 0 Td
(In)Tj
1.1055 0 Td
(COPD)Tj
2.9253 0 Td
(and)Tj
1.7348 0 Td
(asthma,)Tj
3.3165 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8199 0 Td
(as)Tj
1.0148 0 Td
(acute)Tj
2.33 0 Td
(respiratory)Tj
-31.9802 -1.3039 Td
(distress)Tj
3.1917 0 Td
(syndrome)Tj
4.2293 0 Td
(\(ARDS\),)Tj
3.6453 0 Td
(increased)Tj
4.0025 0 Td
(neutrophils)Tj
4.8132 0 Td
(are)Tj
1.4514 0 Td
(seen)Tj
1.9729 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(lungs,)Tj
2.5965 0 Td
(and)Tj
1.7291 0 Td
(increasing)Tj
4.3313 0 Td
(num-)Tj
-34.469 -1.2983 Td
(bers)Tj
1.8765 0 Td
(of)Tj
1.0091 0 Td
(lung)Tj
2.0012 0 Td
(neutrophils)Tj
4.8132 0 Td
(correlate)Tj
3.7134 0 Td
(with)Tj
1.9899 0 Td
(disease)Tj
3.0161 0 Td
(severity)Tj
3.2655 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
3.067 0 Td
(Inhaled)Tj
3.2655 0 Td
(and)Tj
1.7235 0 Td
(systemic)Tj
3.6226 0 Td
(corticoste-)Tj
-33.3635 -1.2982 Td
(roid)Tj
1.8935 0 Td
(therapy)Tj
3.2428 0 Td
(has)Tj
1.5477 0 Td
(therefore)Tj
3.8494 0 Td
(been)Tj
2.126 0 Td
(a)Tj
0.652 0 Td
(mainstay)Tj
3.838 0 Td
(for)Tj
1.3833 0 Td
(treating)Tj
3.3279 0 Td
(these)Tj
2.2564 0 Td
(diseases;)Tj
3.5999 0 Td
(however,)Tj
3.8381 0 Td
(certain)Tj
-31.555 -1.3039 Td
(phenotypes)Tj
4.7961 0 Td
(of)Tj
1.0148 0 Td
(these)Tj
2.2564 0 Td
(disease)Tj
3.016 0 Td
(are)Tj
1.4514 0 Td
(insensitive)Tj
4.439 0 Td
(to)Tj
1.0261 0 Td
(steroid)Tj
2.9764 0 Td
(therapy)Tj
3.2428 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
2.0806 0 Td
(Efforts)Tj
2.9027 0 Td
(to)Tj
1.0261 0 Td
(identify)Tj
3.2939 0 Td
(new)Tj
1.8765 0 Td
(anti-)Tj
-35.3988 -1.2983 Td
(inflammatory)Tj
5.7089 0 Td
(treatments)Tj
4.4957 0 Td
(to)Tj
1.0261 0 Td
(overcome)Tj
4.1499 0 Td
(such)Tj
2.058 0 Td
(treatment)Tj
4.1385 0 Td
(resistance)Tj
4.1273 0 Td
(or)Tj
1.0998 0 Td
(to)Tj
1.0261 0 Td
(reduce)Tj
2.9197 0 Td
(the)Tj
1.4683 0 Td
(functional)Tj
-32.2183 -1.2983 Td
(impact)Tj
2.9763 0 Td
(of)Tj
1.0148 0 Td
(lung)Tj
2.0126 0 Td
(disease,)Tj
3.2428 0 Td
(however,)Tj
3.8324 0 Td
(have)Tj
2.0636 0 Td
(met)Tj
1.7632 0 Td
(with)Tj
1.9955 0 Td
(limited)Tj
3.0671 0 Td
(success)Tj
3.1011 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(].)Tj
-23.8732 -1.3039 Td
(Two)Tj
2.0239 0 Td
(factors)Tj
2.9026 0 Td
(contribute)Tj
4.3937 0 Td
(in)Tj
1.0375 0 Td
(part)Tj
1.8368 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
1.4683 0 Td
(limited)Tj
3.0727 0 Td
(successes)Tj
3.8835 0 Td
(of)Tj
1.0148 0 Td
(lung)Tj
2.0069 0 Td
(anti-inflammatory)Tj
7.6081 0 Td
(drug)Tj
-33.4712 -1.2983 Td
(development.)Tj
5.6352 0 Td
(One)Tj
1.9389 0 Td
(is)Tj
0.8447 0 Td
(the)Tj
1.474 0 Td
(inability)Tj
3.5093 0 Td
(of)Tj
1.0148 0 Td
(animal)Tj
2.9707 0 Td
(models)Tj
3.101 0 Td
(to)Tj
1.0262 0 Td
(predict)Tj
3.05 0 Td
(whether)Tj
3.4753 0 Td
(pulmonary)Tj
4.6488 0 Td
(anti-inflam-)Tj
-32.6889 -1.2982 Td
(matory)Tj
3.101 0 Td
(drugs)Tj
2.4775 0 Td
(will)Tj
1.6611 0 Td
(be)Tj
1.1508 0 Td
(effective)Tj
3.5093 0 Td
(in)Tj
1.0375 0 Td
(humans)Tj
3.4356 0 Td
(has)Tj
1.5477 0 Td
(contributed)Tj
4.9152 0 Td
(in)Tj
1.0375 0 Td
(part)Tj
1.8425 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(difficulties)Tj
4.405 0 Td
(of)Tj
1.0148 0 Td
(drug)Tj
-33.63 -1.3039 Td
(development)Tj
5.4084 0 Td
(in)Tj
1.0375 0 Td
(this)Tj
1.6724 0 Td
(area)Tj
1.8822 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7348 0 Td
(18)Tj
0 g
(].)Tj
1.7405 0 Td
(Therefore,)Tj
4.3936 0 Td
(human)Tj
3.0728 0 Td
(models)Tj
3.1067 0 Td
(would)Tj
2.7156 0 Td
(potentially)Tj
4.4617 0 Td
(be)Tj
1.1452 0 Td
(of)Tj
1.0205 0 Td
(greater)Tj
-33.3919 -1.2983 Td
(value)Tj
2.3073 0 Td
(for)Tj
1.3833 0 Td
(studying)Tj
3.6737 0 Td
(inflammatory)Tj
5.7033 0 Td
(pathways)Tj
3.9344 0 Td
(and)Tj
1.7292 0 Td
(may)Tj
1.9275 0 Td
(better)Tj
2.5455 0 Td
(predict)Tj
3.0444 0 Td
(the)Tj
1.474 0 Td
(efficacy)Tj
3.2201 0 Td
(of)Tj
1.0148 0 Td
(pulmonary)Tj
-31.9575 -1.2983 Td
(anti-inflammatory)Tj
7.6081 0 Td
(drugs.)Tj
2.6986 0 Td
(One)Tj
1.9388 0 Td
(such)Tj
2.058 0 Td
(model)Tj
2.7439 0 Td
(of)Tj
1.0148 0 Td
(experimentally)Tj
6.1568 0 Td
(induced)Tj
3.4696 0 Td
(lung)Tj
2.0069 0 Td
(inflammation)Tj
5.6976 0 Td
(using)Tj
-35.3931 -1.2982 Td
(endobronchially)Tj
6.7577 0 Td
(instilled)Tj
3.4072 0 Td
(endotoxin)Tj
4.3143 0 Td
(in)Tj
1.0318 0 Td
(healthy)Tj
3.1351 0 Td
(volunteers)Tj
4.3824 0 Td
(was)Tj
1.6951 0 Td
(developed)Tj
4.2746 0 Td
(for)Tj
1.3833 0 Td
(this)Tj
1.6781 0 Td
(purpose)Tj
3.4412 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
-35.5008 -1.3039 Td
(In)Tj
1.1055 0 Td
(this)Tj
1.6781 0 Td
(model,)Tj
2.965 0 Td
(the)Tj
1.474 0 Td
(endotoxin)Tj
4.3086 0 Td
(leads)Tj
2.2167 0 Td
(to)Tj
1.0205 0 Td
(a)Tj
0.6576 0 Td
(self-limited,)Tj
4.9606 0 Td
(neutrophilic)Tj
5.1477 0 Td
(inflammatory)Tj
5.7089 0 Td
(response)Tj
3.7304 0 Td
(that)Tj
-34.9736 -1.2983 Td
(exhibits)Tj
3.3335 0 Td
(proteomic)Tj
4.354 0 Td
(responses)Tj
4.0988 0 Td
(similar)Tj
2.9821 0 Td
(to)Tj
1.0261 0 Td
(those)Tj
2.3357 0 Td
(seen)Tj
1.9786 0 Td
(in)Tj
1.0375 0 Td
(ARDS)Tj
2.7382 0 Td
(patients)Tj
3.3676 0 Td
([)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(].)Tj
2.0749 0 Td
(Therefore,)Tj
4.3937 0 Td
(this)Tj
-33.7207 -1.2983 Td
(model)Tj
2.7439 0 Td
(could)Tj
2.4491 0 Td
(be)Tj
1.1508 0 Td
(used)Tj
2.0637 0 Td
(to)Tj
1.0204 0 Td
(assess)Tj
2.5228 0 Td
(the)Tj
1.4684 0 Td
(effects)Tj
2.7269 0 Td
(of)Tj
1.0148 0 Td
(anti-inflammatory)Tj
7.6081 0 Td
(drugs)Tj
2.4718 0 Td
(in)Tj
1.0375 0 Td
(humans.)Tj
-27.082 -1.3039 Td
(Another)Tj
3.5829 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4684 0 Td
(lack)Tj
1.8198 0 Td
(of)Tj
1.0148 0 Td
(noninvasive,)Tj
5.2611 0 Td
(quantitative)Tj
4.9776 0 Td
(biomarkers)Tj
4.7791 0 Td
(that)Tj
1.7745 0 Td
(accurately)Tj
4.2576 0 Td
(reflect)Tj
2.6986 0 Td
(the)Tj
1.4683 0 Td
(bur-)Tj
-35.1493 -1.2983 Td
(den)Tj
1.7121 0 Td
(of)Tj
1.0091 0 Td
(inflammation)Tj
5.6863 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.4626 0 Td
(lungs)Tj
2.3584 0 Td
(further)Tj
3.0218 0 Td
(hampers)Tj
3.668 0 Td
(anti-inflammatory)Tj
7.6024 0 Td
(drug)Tj
2.1033 0 Td
(development)Tj
5.4028 0 Td
(efforts)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 328.8755 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(FDG)Tj
2.3173 0 Td
(PET)Tj
2.1402 0 Td
(shows)Tj
3.0118 0 Td
(no)Tj
1.311 0 Td
(anti-inflam)Tj
4.5213 0 Td
(matory)Tj
3.2386 0 Td
(effect)Tj
2.6292 0 Td
(of)Tj
1.0417 0 Td
(pioglit)Tj
2.5441 0 Td
(azone)Tj
2.8985 0 Td
(and)Tj
1.8567 0 Td
(zileuton)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01917)Tj
4.089 0 Td
(83)Tj
0 g
2.0906 0 Td
(February)Tj
4.1599 0 Td
(7,)Tj
1.0417 0 Td
(2018)Tj
33.7042 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(17)Tj
ET
Q
q
0.83 0.64 0.02 0 k
1 j
1 J
0 w
36 707.6409 m
96.8882 707.6409 l
h
f*
7.9999 0 0 7.9999 36 708.7181 cm
BT
/F9 1 Tf
1 TL
-0.025 Tc
0 0 Td
(developm)Tj
3.6283 0 Td
(ent-award/)Tj
0 g
(\))Tj
4.5071 0 Td
(as)Tj
1.063 0 Td
(well)Tj
1.6654 0 Td
(as)Tj
1.063 0 Td
(the)Tj
1.3677 0 Td
(National)Tj
3.2457 0 Td
(Heart,)Tj
-16.5402 -1.3748 Td
(Lung)Tj
2.1118 0 Td
(and)Tj
1.5874 0 Td
(Blood)Tj
2.3599 0 Td
(Institute)Tj
3.2244 0 Td
(grant)Tj
2.1543 0 Td
(R01)Tj
1.7504 0 Td
(HL116389)Tj
4.1245 0 Td
(to)Tj
-17.3127 -1.3748 Td
(DLC,)Tj
2.0338 0 Td
(the)Tj
1.3678 0 Td
(Washingto)Tj
3.9897 0 Td
(n)Tj
0.6945 0 Td
(University)Tj
3.9119 0 Td
(Institute)Tj
3.2244 0 Td
(of)Tj
0.9496 0 Td
(Clinical)Tj
-16.1717 -1.3748 Td
(and)Tj
1.5874 0 Td
(Translationa)Tj
4.5283 0 Td
(l)Tj
0.4111 0 Td
(Sciences)Tj
3.522 0 Td
(grant)Tj
2.1544 0 Td
(UL1)Tj
1.7504 0 Td
(TR000448)Tj
-13.9536 -1.3748 Td
(from)Tj
2.0126 0 Td
(the)Tj
1.3677 0 Td
(National)Tj
3.2386 0 Td
(Center)Tj
2.6221 0 Td
(for)Tj
1.2614 0 Td
(Advancing)Tj
-10.5024 -1.3748 Td
(Translationa)Tj
4.5283 0 Td
(l)Tj
0.4111 0 Td
(Sciences,)Tj
3.7417 0 Td
(and)Tj
1.5945 0 Td
(P30)Tj
1.6866 0 Td
(DK020579)Tj
4.1741 0 Td
(from)Tj
-16.1363 -1.3748 Td
(the)Tj
1.3677 0 Td
(National)Tj
3.2386 0 Td
(Institute)Tj
3.2244 0 Td
(of)Tj
0.9496 0 Td
(Diabetes)Tj
3.4158 0 Td
(and)Tj
1.5874 0 Td
(Digestive)Tj
3.6071 0 Td
(and)Tj
-17.3906 -1.3748 Td
(Kidney)Tj
2.7283 0 Td
(Diseases)Tj
3.5292 0 Td
(of)Tj
0.9496 0 Td
(the)Tj
1.3677 0 Td
(National)Tj
3.2386 0 Td
(Institutes)Tj
3.6497 0 Td
(of)Tj
0.9496 0 Td
(Health)Tj
-16.4127 -1.3749 Td
(\(NIH\).)Tj
2.4874 0 Td
(The)Tj
1.5874 0 Td
(content)Tj
2.9976 0 Td
(is)Tj
0.8363 0 Td
(solely)Tj
2.3386 0 Td
(the)Tj
1.3748 0 Td
(responsibi)Tj
3.8481 0 Td
(lity)Tj
1.2826 0 Td
(of)Tj
0.9497 0 Td
(the)Tj
-17.7025 -1.3748 Td
(authors)Tj
3.0472 0 Td
(and)Tj
1.5874 0 Td
(does)Tj
2.0126 0 Td
(not)Tj
1.4174 0 Td
(necessarily)Tj
4.337 0 Td
(represent)Tj
3.7276 0 Td
(the)Tj
-16.1292 -1.3748 Td
(official)Tj
2.6291 0 Td
(view)Tj
1.8921 0 Td
(of)Tj
0.9497 0 Td
(the)Tj
1.3677 0 Td
(NIH.)Tj
/F8 1 Tf
-6.8386 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F9 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(have)Tj
1.963 0 Td
(declared)Tj
-14.7827 -1.3748 Td
(that)Tj
1.6228 0 Td
(no)Tj
1.1693 0 Td
(competing)Tj
4.1599 0 Td
(interests)Tj
3.3874 0 Td
(exist.)Tj
/F8 1 Tf
-10.3394 -2.126 Td
(Abbreviati)Tj
3.9118 0 Td
(ons:)Tj
ET
Q
q
1 j
1 J
0 w
5.9998 0 0 5.3325 82.0346 557.2913 cm
BT
/F9 1 Tf
1 TL
-0.0334 Tc
0 0 Td
(18)Tj
ET
Q
q
1 j
1 J
0 w
7.9999 0 0 7.9999 87.6472 553.7196 cm
BT
/F9 1 Tf
1 TL
-0.025 Tc
0 0 Td
(F-FDG,)Tj
ET
Q
q
1 j
1 J
0 w
5.9998 0 0 5.3325 109.8141 557.2913 cm
BT
/F9 1 Tf
1 TL
-0.0334 Tc
0 0 Td
(18)Tj
ET
Q
q
1 j
1 J
0 w
7.9999 0 0 7.9999 115.4267 553.7196 cm
BT
/F9 1 Tf
1 TL
-0.025 Tc
0 0 Td
(F-Fluorode)Tj
3.9614 0 Td
(oxyglucose;)Tj
-13.8898 -1.3748 Td
(ANOVA,)Tj
3.1961 0 Td
(Analysis)Tj
3.2882 0 Td
(of)Tj
0.9496 0 Td
(variance;)Tj
3.5291 0 Td
(ARDS,)Tj
2.6646 0 Td
(Acute)Tj
-13.6276 -1.3748 Td
(respirator)Tj
3.5788 0 Td
(y)Tj
0.6449 0 Td
(distress)Tj
3.1323 0 Td
(syndrome;)Tj
4.1952 0 Td
(BAL,)Tj
-11.5512 -1.3748 Td
(Bronchoalv)Tj
4.1812 0 Td
(eolar)Tj
2.0409 0 Td
(lavage;)Tj
2.7922 0 Td
(COPD,)Tj
2.6715 0 Td
(Chronic)Tj
3.0898 0 Td
(obstructiv)Tj
3.6922 0 Td
(e)Tj
-18.4678 -1.3748 Td
(pulmonary)Tj
4.2095 0 Td
(disease;)Tj
3.2174 0 Td
(CRP,)Tj
2.0834 0 Td
(C-reactive)Tj
3.9189 0 Td
(protein;)Tj
3.0401 0 Td
(CT,)Tj
-16.4693 -1.3748 Td
(Computed)Tj
4.0678 0 Td
(tomography;)Tj
4.9748 0 Td
(ELISA,)Tj
2.6929 0 Td
(Enzyme-lin)Tj
4.0677 0 Td
(ked)Tj
-15.8032 -1.3748 Td
(immunosor)Tj
4.3229 0 Td
(bent)Tj
1.8425 0 Td
(assay;)Tj
2.5512 0 Td
(ESR,)Tj
2.0338 0 Td
(Erythrocy)Tj
3.5504 0 Td
(te)Tj
-14.3008 -1.3748 Td
(sedimentat)Tj
4.089 0 Td
(ion)Tj
1.3607 0 Td
(rate;)Tj
1.8496 0 Td
(FEV1,)Tj
2.3386 0 Td
(Forced)Tj
2.7354 0 Td
(expiratory)Tj
-12.3733 -1.3749 Td
(volume)Tj
2.9552 0 Td
(in)Tj
0.8858 0 Td
(1)Tj
0.6945 0 Td
(second;)Tj
3.1323 0 Td
(FVC,)Tj
1.9134 0 Td
(Forced)Tj
2.7354 0 Td
(vital)Tj
1.7078 0 Td
(capacity;)Tj
3.4725 0 Td
(i.b.,)Tj
-17.4969 -1.3748 Td
(Intrabron)Tj
3.4371 0 Td
(chial;)Tj
2.1472 0 Td
(LTE4,)Tj
2.3386 0 Td
(Leukotriene)Tj
4.5567 0 Td
(E4;)Tj
1.3889 0 Td
(NIH,)Tj
1.878 0 Td
(National)Tj
-15.7465 -1.3748 Td
(Institutes)Tj
3.6426 0 Td
(of)Tj
0.9496 0 Td
(Health;)Tj
2.7992 0 Td
(PET,)Tj
1.9134 0 Td
(Positron)Tj
3.3448 0 Td
(emission)Tj
-12.6496 -1.3748 Td
(tomograp)Tj
3.6284 0 Td
(hy;)Tj
1.3394 0 Td
(PPAR,)Tj
2.6079 0 Td
(Peroxisome)Tj
4.6346 0 Td
(proliferator-)Tj
-12.2103 -1.3748 Td
(activated)Tj
3.5079 0 Td
(receptor)Tj
3.0756 0 Td
(;)Tj
0.4465 0 Td
(SUV)Tj
ET
Q
q
1 j
1 J
0 w
5.9998 0 0 5.3325 105.3354 420.3779 cm
BT
/F9 1 Tf
1 TL
-0.0334 Tc
0 0 Td
(mean)Tj
ET
Q
q
1 j
1 J
0 w
7.9999 0 0 7.9999 117.5811 421.7385 cm
BT
/F9 1 Tf
1 TL
-0.025 Tc
0 0 Td
(,)Tj
0.4464 0 Td
(Mean)Tj
2.289 0 Td
(standard)Tj
3.4654 0 Td
(uptake)Tj
-16.3985 -1.3748 Td
(value;)Tj
2.3741 0 Td
(TLR4,)Tj
2.452 0 Td
(Toll-like)Tj
3.0897 0 Td
(receptor)Tj
ET
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
BT
1.0204 -1.3748 Td
(4.)Tj
ET
Q
endstream
endobj
44 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 48 0 R/Contents 49 0 R/TrimBox[0 0 612 792]>>
endobj
45 0 obj
<>
endobj
50 0 obj
<>stream
/CIDInit/ProcSet findresource begin
12 dict begin begincmap
/CMapName/Adobe-Identity-UCS def
/CIDSystemInfo<>def
/CMapType 2 def
1 begincodespacerange
<0000>
endcodespacerange
1 beginbfchar
<010D><03B3>
endbfchar
endcmap
CMapName currentdict /CMap defineresource pop end end
endstream
endobj
51 0 obj
<>/FontDescriptor 52 0 R/DW 250/W[269[465]]>>
endobj
52 0 obj
<>
endobj
53 0 obj
<>stream
cvt f6 fpgm2Msf bglyfW headtr 6hhea1 $hmtx&O